Cellectar Biosciences, Inc. (CLRB) Current Reports & Earnings Releases
Upcoming
- 2026-11-12 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-10 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-18 | 8-K | Officer / Director Changes | SEC |
| 2026-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-05-08 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-10 | 8-K | Material Agreement, Results of Operations, Unregistered Sales, Item 3.03, Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-06 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-26 | 8-K | Other Events | SEC |
| 2025-06-25 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-13 | 8-K | Shareholder Vote Results | SEC |
| 2025-06-05 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-05-01 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-17 | 8-K | Officer / Director Changes, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-03-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-31 | 8-K | Listing Notice | SEC |
| 2025-01-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-12-11 | 8-K | Item 2.05, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-18 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-11-15 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-01 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-23 | 8-K | Listing Notice, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-09 | 8-K | Non-Reliance on Financials | SEC |
| 2024-07-23 | 8-K | Results of Operations, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-22 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-07-11 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2024-06-25 | 8-K | Material Agreement, Direct Financial Obligation | SEC |
| 2024-06-14 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-02 | 8-K | Other Events | SEC |
| 2024-01-25 | 8-K | Other Events | SEC |
| 2024-01-09 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.